CoChat

Telomere shortening is a hallmark of genetic cardiomyopathies

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Significance: We find that telomere shortening, which usually accompanies cell division in the course of aging, occurs in cardiomyocytes (CMs) of individuals with genetic hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM). HCM and DCM CMs differentiated from human-induced pluripotent stem cells (hiPSCs) also exhibit significant telomere shortening relative to healthy controls. By contrast, no telomere shortening was detected in vascular smooth muscle cells in tissue or hiPSC-derived cells, a cell type that does not express the mutant proteins. Our findings provide evidence for accelerated aging in CMs with familial cardiomyopathy. The potential to monitor the dynamics of telomere attrition in hiPSC-CMs over time will enable future mechanistic studies and screens for novel therapeutic agents to arrest telomere shortening and disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1714538115

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. HCM and DCM CMs exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of CMs. (B) Patient CMs [cardiac Troponin-T (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 40–220 nuclei per patient tissue) within five to six regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM (*P < 0.05 and ****P < 0.0001).
Fig. 1. HCM and DCM CMs exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of CMs. (B) Patient CMs [cardiac Troponin-T (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 40–220 nuclei per patient tissue) within five to six regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM (*P < 0.05 and ****P < 0.0001).CC BY-NC-ND · PubMed Central
Fig. 2. HCM and DCM VSMCs do not exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of VSMCs. (B) Patient VSMCs [smooth muscle actin (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 30–150 nuclei per patient tissue) within three to four regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM.
Fig. 2. HCM and DCM VSMCs do not exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of VSMCs. (B) Patient VSMCs [smooth muscle actin (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 30–150 nuclei per patient tissue) within three to four regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM.CC BY-NC-ND · PubMed Central
Fig. 3. HCM and DCM hiPSC-derived CMs recapitulate telomere shortening. (A) Patient PBMCs were used to generate patient-specific hiPSC lines and used to differentiate into hiPSC-CMs. (B) Cardiomyopathic patient and control day 30 hiPSC-CMs were used to assess telomere levels. Representative hiPSC-CMs (cardiac Troponin-T; green) were stained for telomeres (red) and nuclear DAPI (blue). (Scale bars, 10 μm.) (C) Telomere signal intensity per DAPI-stained nucleus is shown for HCM, DCM, and control hiPSCs (day 0) and hiPSC-CMs (day 30). hiPSC differentiation was performed in two independent experiments per line from the same passage cells, and telomere levels were scored in a blinded fashion (n = 40–330 nuclei per hiPSC or hiPSC-CM). (D) FACS gating for TMRM sorting. (E) TMRM+ population enriched for CM markers whereas TMRM− population enriched for non-CM markers by RT-qPCR (TMRM+, n = 5; TMRM−, n = 3). (F) Telomere T/S ratio nucleus is shown for HCM (n = 6), DCM (n = 8), and control (n = 8) TMRM+ hiPSC-CMs (day 30). All data plotted as mean ± SEM (*P < 0.05, ***P < 0.001, and ****P < 0.0001).
Fig. 3. HCM and DCM hiPSC-derived CMs recapitulate telomere shortening. (A) Patient PBMCs were used to generate patient-specific hiPSC lines and used to differentiate into hiPSC-CMs. (B) Cardiomyopathic patient and control day 30 hiPSC-CMs were used to assess telomere levels. Representative hiPSC-CMs (cardiac Troponin-T; green) were stained for telomeres (red) and nuclear DAPI (blue). (Scale bars, 10 μm.) (C) Telomere signal intensity per DAPI-stained nucleus is shown for HCM, DCM, and control hiPSCs (day 0) and hiPSC-CMs (day 30). hiPSC differentiation was performed in two independent experiments per line from the same passage cells, and telomere levels were scored in a blinded fashion (n = 40–330 nuclei per hiPSC or hiPSC-CM). (D) FACS gating for TMRM sorting. (E) TMRM+ population enriched for CM markers whereas TMRM− population enriched for non-CM markers by RT-qPCR (TMRM+, n = 5; TMRM−, n = 3). (F) Telomere T/S ratio nucleus is shown for HCM (n = 6), DCM (n = 8), and control (n = 8) TMRM+ hiPSC-CMs (day 30). All data plotted as mean ± SEM (*P < 0.05, ***P < 0.001, and ****P < 0.0001).CC BY-NC-ND · PubMed Central
Fig. 4. HCM and DCM hiPSC-derived VSMCs do not exhibit telomere shortening. (A) Patient PBMCs were used to generate patient-specific hiPSC lines and used to differentiate into hiPSC-VSMCs. (B) Cardiomyopathic patient and control day 14 hiPSC-VSMCs were used to assess telomere signals. Representative hiPSC-VSMCs (smooth muscle actin; green) were stained for telomere signal (red) and nuclear DAPI (blue). (Scale bars, 10 μm.) (C) Telomere signal intensity per DAPI-stained nucleus is shown for HCM, DCM, and control hiPSC-VSMCs. hiPSC-VSMC differentiation was performed in two independent experiments from the same passage cells, and telomere TFUs were scored in a blinded fashion (n = 36–49 nuclei per group) and plotted as mean ± SEM.
Fig. 4. HCM and DCM hiPSC-derived VSMCs do not exhibit telomere shortening. (A) Patient PBMCs were used to generate patient-specific hiPSC lines and used to differentiate into hiPSC-VSMCs. (B) Cardiomyopathic patient and control day 14 hiPSC-VSMCs were used to assess telomere signals. Representative hiPSC-VSMCs (smooth muscle actin; green) were stained for telomere signal (red) and nuclear DAPI (blue). (Scale bars, 10 μm.) (C) Telomere signal intensity per DAPI-stained nucleus is shown for HCM, DCM, and control hiPSC-VSMCs. hiPSC-VSMC differentiation was performed in two independent experiments from the same passage cells, and telomere TFUs were scored in a blinded fashion (n = 36–49 nuclei per group) and plotted as mean ± SEM.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 91

Metadata

Authors
Chang, A. C. Y., Chang, A. C. H., Kirillova, A., Sasagawa, K., Su, W., Weber, G., Lin, J., Termglinchan, V., Karakikes, I., Seeger, T., Dainis, A. M., Hinson, J. T., Seidman, J., Seidman, C. E., Day, J. W., Ashley, E., Wu, J. C., & Blau, H. M.
Affiliations
  • Stanford Medicine (US)
  • University of California, San Francisco (US)
  • Stanford Cardiovascular Institute (US)
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • Stanford University (US)
Corresponding author
  • Chang, Alex C. Y.
  • Blau, Helen M.
Venue
Proceedings of the National Academy of Sciences
Published
2018-08-27
Volume
115
Issue
37
Pages
9276-9281
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2889508731
Cited by
91
References
30
Citations by year
2026: 11 · 2025: 9 · 2024: 15 · 2023: 8 · 2022: 23 · 2021: 9 · 2020: 6 · 2019: 10
FWCI
4.29
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Heart Association (13POST14480004 and 18CDA34110411, 15BGIA22730027, 17MERIT33610009, 17CSA33590101)
  • Gouvernement du Canada | Canadian Institutes of Health Research (201411MFE-338745-169197)
  • Burroughs Wellcome Fund (1015009)
  • HHS | National Institutes of Health (K99 HL104002, K08 HL125807, R01 HL126527, R01 HL130020, R01 HL123968, and R24 HL117756, AG044815 and AR063963)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
telomere shortening, familial cardiomyopathy, hypertrophic cardiomyopathy, dilated cardiomyopathy, human induced pluripotent stem cells, cardiomyocytes, disease modeling, drug discovery
MeSH terms
Cardiomyopathy, Dilated, Cell Division, Female, Humans, Male, Muscle Proteins, Mutation, Cardiomyopathy, Hypertrophic, Familial, Induced Pluripotent Stem Cells, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomere shortening is a hallmark of genetic cardiomyopathies. https://app.cochat.ai/papers/10.1073/pnas.1714538115
The paper
Chang, A. C. Y., Chang, A. C. H., Kirillova, A., Sasagawa, K., Su, W., Weber, G., Lin, J., Termglinchan, V., Karakikes, I., Seeger, T., Dainis, A. M., Hinson, J. T., Seidman, J., Seidman, C. E., Day, J. W., Ashley, E., Wu, J. C., & Blau, H. M. (2018). Telomere shortening is a hallmark of genetic cardiomyopathies. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1714538115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.